17:46 ยท 28 October 2025

Wind turbine maker Nordex surges 19% to 9-year high ๐Ÿ“ˆ

Key takeaways
Key takeaways
  • Nordex surges almost 20% to 9-year high
  • Wind maker reported much higher than expected earnings prelim
  • The company said it now expects its 2025 full-year EBITDA margin to range between 7.5% and 8.5%, compared to the previous forecast of 5%โ€“7%.

Shares of German wind turbine manufacturer Nordex surged sharply on Tuesday morning in European trading after the company raised its full-year operating profit (EBITDA) margin guidance.

  • In a statement, the company said it now expects its 2025 full-year EBITDA margin to range between 7.5% and 8.5%, compared to the previous forecast of 5%–7%.
  • Nordex explained that the improved margin outlook was driven by strong operational performance across its projects and service divisions, as well as a stable macroeconomic environment.
  • All other elements of the guidance remain unchanged — annual revenues are expected to come in between €7.4 billion and €7.9 billion, while capital expenditures are estimated at around €200 million.
  • Analysts at Kepler Cheuvreux said they expect consensus forecasts for 2025 operating profit to rise by approximately 22%, to about €600 million, noting that “strong project execution enabled a higher release of contingencies than initially budgeted at the start of the year.”
  • “We remain focused on driving profitable growth and creating long-term value for our shareholders,” said CEO Jose Luis Blanco in a statement.

The onshore wind turbine group also released preliminary third-quarter results — EBITDA reached €136 million with a margin of 8%, compared to €72 million and 4.3% in the same period last year. Revenue for the quarter is expected to total around €1.706 billion, roughly in line with the prior year, mainly due to seasonal effects and temporary supplier delays in TürkiyeNordex will publish its full third-quarter report on November 4.

 

Source: xStation5

19 June 2026, 17:30

US Closed: Postponed negotiations weigh on futures

19 June 2026, 16:47

Will Massive AI Investments Bring Dark Clouds Over Wall Street?

19 June 2026, 16:14

Market wrap: Limited volatility and a strong dollar

18 June 2026, 21:55

Daily Summary: Dollar at 1-year high, stocks rebound on renewed risk appetite ๐Ÿš€ (18.06.2026)

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the CMA

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the CMA

The financial instruments we offer are risky. XTB is regulated by the CMA.